Search

Search Constraints

You searched for: Author/Creator Ngamsamut, Nattawat

Search Results

1. 9‐Hydroxyrisperidone‐Induced Hyperprolactinaemia in Thai Children and Adolescents with Autism Spectrum Disorder. Issue 3 (18th March 2016)

2. Association between HLA‐B*1502 allele and aromatic antiepileptic drugs‐induced hypersensitivity syndrome reactions and the HLA‐B*15:02 pharmacogenetics screening in autistic spectrum disorder. (18th July 2014)

3. Detection of CYP2D6 polymorphism using Luminex xTAG technology in autism spectrum disorder: CYP2D6 activity score and its association with risperidone levels. Issue 2 (April 2016)

4. Development and Validation of Liquid Chromatography/Tandem Mass Spectrometry Analysis for Therapeutic Drug Monitoring of Risperidone and 9‐Hydroxyrisperidone in Pediatric Patients with Autism Spectrum Disorders. Issue 6 (26th June 2016)

5. Impact of Pharmacogenetic Markers of CYP2D6 and DRD2 on Prolactin Response in Risperidone-Treated Thai Children and Adolescents With Autism Spectrum Disorders. Issue 2 (April 2016)

6. Pharmacogenetics of Risperidone‐Induced Insulin Resistance in Children and Adolescents with Autism Spectrum Disorder. Issue 1 (30th March 2018)

7. Pharmacogenomics and Efficacy of Risperidone Long‐Term Treatment in Thai Autistic Children and Adolescents. Issue 4 (19th June 2017)

8. Risperidone plasma concentrations are associated with hyperprolactinemia in autism spectrum disorder children: The impact of CYP2D6 polymorphisms. (August 2022)

9. Significant Association of HLA-B Alleles and Genotypes in Thai Children with Autism Spectrum Disorders: A Case-Control Study. (24th December 2015)

10. UGT1A1 polymorphisms associated with prolactin response in risperidone-treated children and adolescents with autism spectrum disorder. Issue 6 (December 2018)